MFSSX | NMAAX | MFSSX / NMAAX | |
Total Expense Ratio | 0.82 | 0.79 | 104% |
Annual Report Gross Expense Ratio | 0.87 | 0.79 | 110% |
Fund Existence | 40 years | 31 years | - |
Gain YTD | -1.965 | -2.111 | 93% |
Front Load | 4% | 4% | 101% |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 382M | 384M | 99% |
Annual Yield % from dividends | 3.19 | 3.34 | 96% |
Returns for 1 year | -0.40 | -0.72 | 55% |
Returns for 3 years | 6.28 | 4.65 | 135% |
Returns for 5 years | 1.26 | -1.99 | -63% |
Returns for 10 years | 12.37 | 7.68 | 161% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GNOM | 8.40 | 0.05 | +0.58% |
Global X Genomics & Biotechnology ETF | |||
QQQY | 25.99 | 0.09 | +0.35% |
Defiance Nasdaq 100 Target 30 Income ETF | |||
VONV | 84.86 | 0.26 | +0.31% |
Vanguard Russell 1000 Value ETF | |||
IGOV | 42.84 | -0.11 | -0.26% |
iShares International Treasury Bond ETF | |||
UCO | 22.35 | -0.27 | -1.19% |
ProShares Ultra Bloomberg Crude Oil |